Disclosures
The ORBIT-AF registry is sponsored by Janssen Scientific Affairs, LLC, Raritan, NJ. This project was supported (in part) by funding from the Agency of Healthcare Research and Quality through cooperative agreement number 1U19 HS021092. Dr. Singer was, in part, supported by the Eliot B. and Edith C. Shoolman fund of the Massachusetts General Hospital (Boston, MA).
This work was performed at the Duke Clinical Research Institute, Durham, NC.
Dr. O'Brien and Ms. Holmes report no disclosures. Dr. Ansell reports that he has received Consultant/Advisory Board fees from Bristol Myers Squibb, Pfizer, Janssen, Daiichi, Boehringer Ingelheim, Alere (all modest). Dr. Allen reports consulting fees from Amgen and J&J/Janssen. Dr. Hylek reports that she is a member of the Speakers Bureau (modest) for Boehringer-Ingelheim, Bayer and a member of the Consultant/Advisory Boards (Modest) for Johnson & Johnson, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Ortho-McNeil-Janssen. Dr. Kowey reports that he has served as a Consultant/Advisory Board for Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson, Portola, Merck, Sanofi, Daiichi Sankyo (all modest). Dr. Gersh reports that he is a member of the advisory board for Boston Scientific and St. Jude Medical (both modest). Dr. Fonarow reports that he has served as a Consultant/Advisory Board member for Ortho McNeil. Dr. Ezekowitz is a member of the speakers bureau with Boehringer Ingelheim and consultancy with Boehringer Ingelheim, ARYx Therapeutics, Pfizer, Sanofi, Bristol-Myers-Squibb, Portola, Daiichi Sankyo, Medtronic, Merck, Gilead, and Janssen. Mr. Koller reports no disclosures. Dr. Mahaffey has received research support from AstraZeneca, Amgen, Bayer, Boehringer-Ingleheim, Bristol-Myers-Squibb, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Portola, POZEN Pharmaceutical, Schering-Plough, and The Medicines Company, and has consulting agreements with Amgen, AstraZeneca, Glaxo SmithKline, Johnson & Johnson, and Merck. Dr. Chang is an employee of Janssen. Dr. Peterson has received research support from Eli Lilly & Company and Janssen. Dr. Piccini has received research support from Boston Scientific Corporation and Janssen and consultancies to Forest Laboratories, Janssen, and Medtronic. Dr. Singer reports that he has received a research grant (significant) from Johnson and Johnson and served as a Consultant/Advisory Board member for Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson and Johnson, Pfizer (modest) and Daiichi Sankyo (significant).